Seeking Alpha
21 Oct 2026, 17:47 UTC · 1h ago
Abbott Q3: Nutrition Spin-Out, Narrowed Guidance Rocks Stock; For Now, At Least
Impact · against what's priced in
The spin-off of the Nutrition division and narrowed EPS guidance create near-term headwinds for ABT by removing a diversified revenue safety net and capping short-term profit expectations. While revenue growth remains strong, the market is not yet convinced that this structural shift will unlock the double-digit growth the current valuation requires.
- ABT−0.40
Challenges what's priced in
- The price assumes
the safety of a diversified healthcare conglomerate
The spin-off of the Nutrition division removes a steady revenue stream, undermining the diversified safety the current 32.8x multiple assumes.
What ABT's price assumes · Sep 12
